Tranexamic acid on bleeding rate in rhinoplasty surgery

Investigating the effect of subcutaneous tranexamic acid injection on the amount of bleeding in rhinoplasty surgery under general anesthesia.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210614051574N14

Enrollment

Registered

2022-09-28

Start date

2022-11-05

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding. Postprocedural hemorrhage and hematoma of the spleen following other procedure

Interventions

Intervention 1: Intervention group: Patients in this group, during anesthesia, receive 10 cc of a solution that contains 5 cc of a solution containing half percent lidocaine and epinephrine (1 in four

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age 18 to 50 years Candidate for rhinoplasty Having a score of 1 or 2 based on the American Society of Anesthesiologists Signing the written informed consent to participate in this study

Exclusion criteria

Exclusion criteria: Uncontrolled systemic disease History of malignant hyperthermia Refusing to continue participating in the study Incidence of any complication during surgery

Design outcomes

Primary

Measure	Time frame
Bleeding volume. Timepoint: Within 60 minutes from the start of surgery and every 10 minutes during the first twenty minutes of recovery. Method of measurement: Suction device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Shetabi

Esfahan University of Medical Sciences

parsa.alinezhad85@gmail.com+98 31 3668 0042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026